Because this article [1] reports a clinical trial, additional clinical trial information, including a participant flow diagram and trial registration details, has been added. These revisions are presented below. The authors confirm that these changes do not affect the scientific conclusions of the study.
Figure Correction
A flow diagram (Figure 4) has been added in accordance with clinical trial publication standards. Accordingly, Figures 4–9 have been re-numbered to Figures 5–10, respectively.
Figure 4.
Participant flow diagram.
Figure 4.
Participant flow diagram.
To cite Figure 4, the first paragraph “This article presents … obtained from 34 participants.” in “3. Result” section will be replaced with the following paragraphs:
“47 patients were considered for inclusion in this study, including 4 patients that were checked for compliance with the suitability requirements and 5 patients that refused to participate in this study, leaving a total of 38 patients included in the study (Figure 4).
To evaluate the effectiveness of PRP in the treatment of endometrial thinning, endometrial thickness data obtained from the same women immediately before their inclusion in this study was used as a control.
During this study, 4 participants refused to participate, and their data were excluded from the final results (the reason was the patients’ refusal to participate further).
As a result, the data of 34 patients were analyzed. Dates defining the recruitment and follow-up periods are January–December 2023.
This article presents the interim results of a study on the effect of PRP on endometrial growth and pregnancy.”
Institutional Review Board Statement Correction
The name of the registry, trial registration number, and date of registration are now included in the Institutional Review Board statement. The corrected Institutional Review Board Statement appears below:
This study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the RSE on REM “Scientific and Production Center of Transfusiology” (Protocol No. 4 dated 15 August 2023). This study has been registered in the national registry—JSC “National Center for State Scientific and Technical Expertise” of the Republic of Kazakhstan, registration number 0123RKI0370, dated 1 January 2024.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Potapova, R.K.; Ospanova, M.E.; Abdrakhmanova, S.A.; Makisheva, A.T.; Popkov, N.A.; Zhangaziyeva, K.H.; Bekmakhanova, B.S. The Effect of Platelet-Rich Plasma on Reproductive Outcomes in Women with Repeated Embryo Transfer Failures: A Single-Center Prospective Interventional Clinical Study. Reprod. Med. 2025, 6, 42. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.